Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Syngenta: Worth Watching but Not Yet Ready for InvestingJohn Mylant • Thu, Aug 5, 2010
-
Syngenta Biotechnology Breaks Ground on Beijing R&D CenterChinaBio Today • Wed, Dec 23, 2009
-
Syngenta To Collaborate With Chinese Institute On Improved Crop TraitsChinaBio Today • Fri, Jun 29, 2007
To learn more about Seeking Alpha Pro, click here.
-
PR Newswire (Apr 23, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 15, 2013)
-
PR Newswire (Feb 15, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Jan 17, 2013)
-
PR Newswire (Jan 3, 2013)
-
PR Newswire (Dec 20, 2012)
-
at CNBC.com (Dec 11, 2012)
-
PR Newswire (Dec 4, 2012)
-
PR Newswire (Nov 20, 2012)
-
PR Newswire (Nov 14, 2012)
-
PR Newswire (Nov 13, 2012)
-
PR Newswire (Oct 26, 2012)
-
PR Newswire (Oct 23, 2012)
-
PR Newswire (Oct 22, 2012)
-
PR Newswire (Oct 18, 2012)
-
PR Newswire (Sep 24, 2012)
SYT vs. ETF Alternatives
Company Description
Syngenta AG, a Swiss Aktiengesellschaft, was formed on November 12, 1999 under the laws of Switzerland. In November 2000, Syngenta’s business operations were created by Novartis AG (“Novartis”) and AstraZeneca PLC (“AstraZeneca”) through an agreement to spin off and merge the Novartis... More





